BriLife
experimental COVID-19 vaccine
Facts
8 properties- Instance of
- funded product
- Subclass of
- COVID-19 vaccine, viral vector vaccine, vaccine candidate[4][5][6]
- Manufacturer
- Israel Institute for Biological Research[2]
🏷️ Also known as
en BriLife
en IIBR 100
en IIBR-100
en rVSV-SARS-CoV-2-S
🔖 Identifiers · 2
- Image (Wikimedia Commons)
- Reuven Rivlin with the first vaccinator in Phase B of the Israeli Vaccine of the Israeli Biological Institute, January 2021 (GPOABG 4045).jpg ↗
- Vaccine Ontology ID
- VO_0005090
🔗 Connections
Subclass of 2
Country of origin 1
Developer 1
Funder 1
Manufacturer 1
Route of administration 1
Vaccine for 1
Press Enter · cited answer in seconds
0 sources
Summary
BriLife is a funded product[1].